Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 648.55

+0.2%

2:15 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pseudo Biologist who wrote (340)	12/27/1999 3:14:00 PM
From: Miljenko Zuanic	Read Replies (1) of 3557

<<Let me add that the Yancopoulos body of work on angiogenesis is extremely rich, very hard, for me, to follow, but something bound to yield some very interesting stuff one of these days. I do not mean just beautiful papers in Nature or Science, there are plenty of those already -g->> I guess we are not (not yet) that lucky! biz.yahoo.com I do not know what can move this sucker? <g> Dozen more manuscripts (if anyone start to read them), or that Vogelos sell his remaining MRK position and continue to buy REGN at open market. Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next